Introduction: Removal of tobacco industry branding from cigarette packs may reduce their appeal. Adding graphic warning labels (GWLs) should enhance this effect. We investigate whether willingness to pay for various packaging designs changes after 3 months' use of: (1) US branded packs without GWLs (US), (2) non-branded packs without GWLs (Blank), and (3) rotating non-branded packs with GWLs (gangrene; throat cancer; neonatal baby) covering >75% of pack (GWL).
Methods: Californian adult daily smokers not planning to quit (n=287; 56% female; mean age=39.6) completed a discrete choice purchase task before and after 3 months' experience using one of three packaging options. Conjoint analysis and pre-post modelling evaluated the change in importance of pack attributes and willingness to pay for US, Blank or GWL (blindness; teeth; gangrene) pack designs.
Results: Price determined ~70% of purchase choices, while pack design determined ~22%. Irrespective of intervention arm, US packaging generated appeal valuations compared with Blank packaging, while GWLs consistently provoked strong aversive valuations at baseline and follow-up. Compared with the US pack arm, using GWL packs for 3 months decreased willingness to pay for US packaging (β=-$0.38, 95% CI -0.76 to 0.00). Wear-out effects were detected in the discount needed to willingly purchase the gangrene-GWL pack (β=$0.49, 95% CI 0.16 to 0.82) and Blank pack (β=$0.42, 95% CI 0.09 to 0.74) but not for GWLs (blindness, teeth) not used in trial.
Conclusion: Compared with US branded packs, the negative valuation of non-branded GWL packs attenuates with even 3 months' use but does not generalise to non-used GWLs. This suggests that GWLs should be regularly refreshed. The appeal valuation of industry imagery suggests that the US plan to retain such imagery on packs may ameliorate the effect of GWLs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/tobaccocontrol-2021-057071 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unraveling the genetic architecture of blueberry fruit quality traits: major loci control organic acid content while more complex genetic mechanisms control texture and sugar content.
BMC Plant Biol
January 2025
Plants for Human Health Institute, North Carolina State University, Kannapolis, NC, 28081, USA.
Background: Fruit quality traits, including taste, flavor, texture, and shelf-life, have emerged as important breeding priorities in blueberry (Vaccinium corymbosum). Organic acids and sugars play crucial roles in the perception of blueberry taste/flavor, where low and high consumer liking are correlated with high organic acids and high sugars, respectively. Blueberry texture and appearance are also critical for shelf-life quality and consumers' willingness-to-pay.
View Article and Find Full Text PDFBehaviors and influencing factors of Chinese oncology nurses towards frailty care: A cross-sectional study based on knowledge-attitude-practice theory in 2024.
PLoS One
January 2025
Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Background: The demand for frailty care is continuously increasing in hospitalized tumor patients with the aging of the population. Nurses are the primary care providers of hospitalized tumor patients with frailty but research on exploring their behavior and associated factors is limited. This study aims to describe the current situation of frailty care behaviors in oncology nurses and to explore the factors influencing frailty care behaviors.
View Article and Find Full Text PDFPublic Health.
Alzheimers Dement
December 2024
University of Southern California, Los Angeles, CA, USA.
Background: The value payers and policymakers traditionally place on novel treatments for Alzheimer's and other neurological diseases that cause cognitive impairment (CI) and dementia often ignores disease baseline severity. More patient-centered economic evaluations-such as those estimating "insurance value"-incorporate the fact that individuals are typically risk-averse and place high value on generous coverage of treatments in the event that they develop CI, such as severe dementia, later in life. This study aims to estimate this insurance value, accounting for risk aversion, relative to the value of the same treatment based on traditional payer cost effectiveness approaches.
View Article and Find Full Text PDFPublic Health.
Alzheimers Dement
December 2024
University of Southern California, Los Angeles, CA, USA.
Background: As disease-modifying treatments for Alzheimer's disease (AD) are becoming available in the US, concerns have been raised that an unprepared healthcare system will be unable to cope with the expected influx of patients. Individuals dually eligible for Medicare and Medicaid might be disproportionately affected by wait times for three reasons. They have higher burden of disease; many practices do not accept Medicaid at all and those who do might limit the number of Medicaid patients because of lower payment rates under the so-called lesser-of policy.
View Article and Find Full Text PDFPublic Health.
Alzheimers Dement
December 2024
Alzheimer's Disease & Brain Health, Eisai Inc., Nutley, NJ, USA.
Background: This study describes the total healthcare costs integrating direct, indirect, and intangible or emotional cost components across the severity stages of Alzheimer's disease (AD) in US.
Method: Utilizing Health and Retirement Study (HRS) data (1994-2018), a bi-annual US national survey of older adults, we assessed out-of-pocket and indirect costs, including unpaid caregiving services, missed workdays, and early retirement. HRS, analyzed with sampling weights, provided a representative US national sample.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!